DPP-IV inhibitory potential of naringin: An in silico, in vitro and in vivo study

Diabetes Research and Clinical Practice

Volumn 97, Issue 1, 2012, Pages 105-111

  Parmar, Hamendra Singh ^a   Jain, Palak ^a   Chauhan, Digvijay Singh ^a   Bhinchar, Mahesh Kumar ^a   Munjal, Vibhuti ^a   Yusuf, Mohammed ^a   Choube, Krati ^a   Tawani, Arpita ^a   Tiwari, Vinita ^a   Manivannan, E ^a   Kumar, Anil ^a  

^a DEVI AHILYA UNIVERSITY   (India)

Author keywords

DPP IV; GLP 1; In silico; In vitro; In vivo; Naringin

Indexed keywords

AURANTIIN; DIPEPTIDYL PEPTIDASE IV; GLUCOSE; INSULIN; NITRITE; SITAGLIPTIN;

ANIMAL EXPERIMENT; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DRUG BINDING; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HYDROGEN BOND; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; RAT;

ANIMALS; BLOOD GLUCOSE; COMPUTER SIMULATION; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLAVANONES; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPID PEROXIDATION; MALE; PANCREAS; RATS; RATS, WISTAR;

EID: 84864095846     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.02.011     Document Type: Article

References (26)

1. Rato Q. Diabetes mellitus: a global health problem. Rev Port Cardiol 2010, 29:539-543.
2. White J.R. Dipeptidyl peptidase-IV inhibitors: pharmacological profile and clinical use. Clin Diabetes 2008, 26:53-57.
3. UK Prospective Diabetes Study Group Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 UK Prospective Diabetes Study Group. BMJ 1998, 317:720-726.
4. The DECODE study group on behalf of the European Diabetes Epidemiology Study Group Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe. Diabetologia 1999, 42:647-654.
5. Monnier L., Lapinski H., Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 2003, 26:881-885.
6. Ng V.W.S., Kong A.P.S. Dipeptidyl peptidase (DPP)-IV inhibitor: a novel class of oral anti-hyperglycemic agents. Drug Rev 2007, 12:33-34.
7. Gupta R., Walunj S.S., Tokala R.K., Parsa K.V.L., Singh S.K., Pal M. Emerging drug candidates of dipeptidyl peptidase IV (DPP IV) inhibitor class for the treatment of type 2 diabetes. Curr Drug Targets 2009, 10:71-87.
8. Srinivasan B.T., Jarvis J., Khunti K., Davies M.J. Recent advances in the management of type 2 diabetes mellitus: a review. Postgrad Med J 2008, 84:524-531.
9. Parmar H.S., Dixit Y., Kar A. Fruit and vegetable peels: paving the way towards the development of new generation therapeutics. Drug Discov Therap 2010, 4:314-325.
10. Jung U.J., Lee M.K., Jeong K.S., Choi M.S. The hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db mice. J Nutr 2004, 134:2499-2503.
11. Choi M.S., Do K.M., Park Y.S., Jeon M.S., Jeong T.S., Lee Y.K., et al. Effect of naringin supplementation on cholesterol metabolism and antioxidant status in rats fed high cholesterol with different levels of vitamin E. Nutr Metab 2001, 45:193-201.
12. Choe S.C., Kim H.S., Jeong T.S., Bok S.H., Park Y.B.J. Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits. Cardiovasc Pharmacol 2001, 38:947-955.
13. Jain M., Parmar H.S. Evaluation of antioxidative and anti-inflammatory potential of hesperidin and naringin on the rat air pouch model of inflammation. Inflamm Res 2011, 60:483-491.
14. Al-masri I.M., Mohammad M.K., Taha M.O. Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening. Chem Med Chem 2008, 3:1763-1779.
15. Pacheco B.P., Crajoinas R.O., Couto G.K., Davel A.P., Lessa L.M., Rossoni L.V., et al. Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats. Hypertens 2011, 29:520-528.
16. Mavropoulos J.C., Miguel C., Carolinallanos L., Juan C.A., Hector G., Salvatore V.P., et al. Anti-tumor necrosis factor-α therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis. J Rheumatol 2005, 32:2116-2124.
17. Sethi A., Parmar H.S., Kumar A. The effect of aspirin on atherogenic diet-induced diabetes mellitus. Basic Clin Pharmacol Toxicol 2011, 108:371-377.
18. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with non-carcinogenic chromogen. J Clin Pathol 1969, 22:158-161.
19. Parmar H.S., Kar A. Medicinal values of fruit peels from Citrus sinensis, Punica granatum, and Musa paradisiaca with respect to alterations in tissue lipid peroxidation and serum concentration of glucose, insulin, and thyroid hormones. J Med Food 2008, 11:376-381.
20. Parmar H.S., Kar A. Comparative analysis of free radical scavenging potential of several fruit peel extracts by in vitro methods. Drug Discov Ther 2009, 3:49-55.
21. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
22. Ferreira L., Teixeira-de-Lemos E., Pinto F., Parada B., Mega C., Vala H., et al. Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat). Mediators Inflamm 2010, 2010:1-11.
23. Souza-Melllo V., Gregorio B.M., Relvas-Lucas B., da-Silva Faria T., Aquilla M.B., Mandarim-de-Lacerda C.A. Pancreatic ultrastructural enhancement due to telmisartan plus sitagliptin treatment in diet-induced obese C57BL/6 mice. Pancreas 2011, 40:715-722.
24. Amudha K., Pari L. Beneficial role of naringin, a flavanoid on nickel induced nephrotoxicity in rats. Chem Biol Interact 2011, 193:57-64.
25. Jagetia G.C., Reddy T.K. Alleviation of iron induced oxidative stress by the grape fruit flavanone naringin in vitro. Chem Biol Interact 2011, 190:121-128.
26. Shimabukuro M., Zhou Y.T., Levi M., Unger R.H. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 1998, 95:2498-25502.